Wenjian Qian

Title: Innovations of Wenjian Qian in Pharmaceutical Development

Introduction

Wenjian Qian is a notable inventor based in Zhejiang, China, recognized for his contributions to the field of pharmaceuticals. He has been instrumental in developing innovative compounds that have potential therapeutic applications. With a total of two patents to his name, Qian's work focuses on creating effective medical treatments.

Latest Patents

Wenjian Qian's latest patents include a piperazine amide derivative and an indazole amine derivative. The piperazine amide derivative is described as a therapeutic agent, particularly as a selective Rearranged During Transfection (RET) kinase inhibitor. This invention outlines a preparation method and the pharmaceutical composition of the derivative, which is represented by a specific formula. The second patent, concerning the indazole amine derivative, provides a preparation method and medical use of the compound, which is particularly useful as an interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor.

Career Highlights

Qian is associated with Zhejiang Hisun Pharmaceutical Co., Ltd., where he has made significant strides in pharmaceutical research and development. His work has contributed to advancements in therapeutic agents that target specific kinases, which are crucial in various medical treatments.

Collaborations

Wenjian Qian has collaborated with notable colleagues, including Cheng Ye and Taishan Hu, to further enhance the research and development of innovative pharmaceutical solutions.

Conclusion

Wenjian Qian's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to advancing medical science. His work continues to pave the way for new therapeutic options in medicine.